ABBOTT INDIA
|
The Current P/E Ratio of ABBOTT INDIA is 53.41.
Share Price | ₹35,637.4 | Jun 30,2025 |
Market Cap | ₹75,551.3 Cr | |
Earnings-TTM | ₹1,414.4 Cr | TTM-Standalone Results |
Price/Earnings | 53.41x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ABBOTT INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹75,551.3 Cr] as on Jun 30,2025
(/) Earnings [ ₹1,414.4 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 53.41x ]
Thus, for ABBOTT INDIA , the investors are currently willing to pay 53.41 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ABBOTT INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ABBOTT INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of ABBOTT INDIA
PE Ratio Performance Analysis for ABBOTT INDIA
- ABBOTT INDIA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 49.14x.
- ABBOTT INDIA 's operated at median p/e ratio of 47.67x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ABBOTT INDIA 's p/e ratio peaked in Mar2020 at 55.39x.
- ABBOTT INDIA 's p/e ratio hit its five-year low in Mar2021 of 46.11x.
How does ABBOTT INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ABBOTT INDIA | 1,414.44 | 53.41 | 75,551.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.64 | 402,320.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 82.53 | 180,823.0 |
CIPLA LTD | 5,291.05 | 22.98 | 121,591.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 60.39 | 115,400.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.78 | 107,135.0 |
MANKIND PHARMA LTD | 2,003.22 | 47.86 | 95,868.6 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.58 | 99,576.9 |
LUPIN LTD | 3,306.26 | 26.77 | 88,502.5 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.75 | 65,926.8 |
ALKEM LABORATORIES LTD | 2,216.00 | 26.64 | 59,029.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ABBOTT INDIA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.75x |
Max industry PE | 82.53x |
Median industry PE | 26.77x |
Average industry PE | 37.85x |
You may also like the below Video Courses